Abstract: Macrophage Checkpoint Blockade in a Cell-Based Immunotherapy Can Generate Durable and Safe Cures in a Poorly Immunogenic, Syngeneic Mouse Tumor Model (2018 AIChE Annual Meeting)

532354 Macrophage Checkpoint Blockade in a Cell-Based Immunotherapy Can Generate Durable and Safe Cures in a Poorly Immunogenic, Syngeneic Mouse Tumor Model

Lawrence J. Dooling, Jason C. Andrechak, Cory Alvey and Dennis E. Discher, Chemical and Biomolecular Engineering, University of Pennsylvania, Philadelphia, PA

See more of this Session: Immunotherapy Applications
See more of this Group/Topical: Topical Conference: Immunotherapy